**Question:** Mechanism of action of sildenafil is: March 2012

**Core Concept:** Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor, which is used for the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It works by inhibiting the enzyme PDE5, which breaks down cyclic guanosine monophosphate (cGMP), a key mediator in the erectile process.

**Why the Correct Answer is Right:**

Sildenafil (Viagra) works by inhibiting the phosphodiesterase type 5 (PDE5) enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP). cGMP plays a crucial role in the erectile process, and its increased levels lead to smooth muscle relaxation in the penile corpus cavernosum, allowing for penile erection.

**Why Each Wrong Option is Incorrect:**

A. Sildenafil does not directly increase nitric oxide (NO) levels, as this is a precursor for cGMP synthesis, not a target of PDE5 inhibition.
B. Although sildenafil is a PDE5 inhibitor, it does not directly target cyclic adenosine monophosphate (cAMP), another cyclic nucleotide involved in cell signaling.
C. Sildenafil does not inhibit nitric oxide synthase (NOS), the enzyme responsible for NO production, as it specifically targets PDE5.
D. Sildenafil does not primarily act on cGMP breakdown, as it inhibits PDE5, but the correct answer is based on understanding the role of cGMP in the erectile process.

**Clinical Pearl:** Understanding the role of cyclic nucleotides (cGMP and cAMP) in the erectile process is essential for grasping the mechanism of action of PDE5 inhibitors like sildenafil. These drugs are helpful in treating ED by increasing cGMP levels, leading to smooth muscle relaxation and erectile function improvement.

**Correct Answer:** D (sildenafil primarily acts on cGMP breakdown)

**Why Each Wrong Option is Incorrect:**

A. Inhibition of cAMP is not the primary mechanism of action for sildenafil, as cAMP and cGMP are involved in different cellular signaling pathways.
B. Although sildenafil inhibits PDE5, targeting cGMP breakdown is the correct mechanism, not the inhibition of NOS or PDE6, which are unrelated to the erectile process.
C. Inhibition of NOS does not explain the mechanism of action for sildenafil, as it targets PDE5 and cGMP breakdown.

**Clinical Correlation:** Understanding the role of cyclic nucleotides and PDE5 inhibition in the context of erectile dysfunction treatment is crucial for medical students and practitioners. This knowledge helps in explaining the therapeutic action of PDE5 inhibitors like sildenafil and understanding the pathophysiology of erectile dysfunction.